HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emiel F M Wouters Selected Research

vitamin K1 hydroquinone

12/2021Reduced Vitamin K Status as a Potentially Modifiable Risk Factor of Severe Coronavirus Disease 2019.
7/2019Low Vitamin K Status Is Associated with Increased Elastin Degradation in Chronic Obstructive Pulmonary Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emiel F M Wouters Research Topics

Disease

175Chronic Obstructive Pulmonary Disease (COPD)
01/2022 - 01/2002
42Inflammation (Inflammations)
01/2021 - 07/2003
25Dyspnea (Shortness of Breath)
01/2021 - 07/2002
18Emphysema
01/2022 - 01/2002
15Pneumonia (Pneumonitis)
12/2021 - 01/2002
14Asthma (Bronchial Asthma)
01/2021 - 01/2005
14Fatigue
05/2020 - 07/2002
8Osteoporosis
03/2020 - 08/2009
7Body Weight (Weight, Body)
06/2014 - 10/2004
6Lung Diseases (Lung Disease)
11/2021 - 04/2003
5Silicosis
01/2018 - 02/2012
4Respiratory Tract Diseases (Respiratory Tract Disease)
01/2022 - 12/2009
4Obstructive Lung Diseases (Obstructive Lung Disease)
12/2021 - 03/2011
4Heart Failure
02/2021 - 07/2009
4Cardiovascular Diseases (Cardiovascular Disease)
03/2020 - 03/2011
4Hypoxia (Hypoxemia)
01/2017 - 07/2011
3Chronic Kidney Failure (Chronic Renal Failure)
02/2021 - 05/2012
3Respiratory Insufficiency (Respiratory Failure)
12/2020 - 03/2016
3Weight Loss (Weight Reduction)
05/2020 - 10/2004
3Cachexia
05/2020 - 04/2006
3Fibrosis (Cirrhosis)
11/2018 - 08/2009
3Neoplasms (Cancer)
11/2017 - 07/2002
3Lung Injury
06/2016 - 02/2014
2Disease Progression
11/2021 - 09/2010
2Anorexia
05/2020 - 10/2004
2Death (Near-Death Experience)
06/2019 - 06/2015
2Eosinophilia
11/2018 - 11/2017
2Idiopathic Pulmonary Fibrosis
11/2018 - 01/2018
2Chronic Disease (Chronic Diseases)
01/2018 - 08/2012
2Cognitive Dysfunction
05/2017 - 01/2017
2Obesity
10/2016 - 06/2016
2Infections
06/2016 - 02/2014
2Respiratory Hypersensitivity
03/2016 - 03/2007

Drug/Important Bio-Agent (IBA)

26GoldIBA
02/2021 - 01/2005
24Biomarkers (Surrogate Marker)IBA
03/2020 - 06/2010
19Oxygen (Dioxygen)IBA
01/2021 - 06/2010
13Proteins (Proteins, Gene)FDA Link
12/2021 - 04/2003
12CytokinesIBA
01/2021 - 01/2002
11SmokeIBA
01/2022 - 08/2002
10C-Reactive ProteinIBA
05/2020 - 03/2006
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2014 - 01/2002
9Bronchodilator Agents (Bronchodilators)IBA
01/2022 - 12/2005
9prednylidene (Pred)IBA
11/2020 - 06/2008
9Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020 - 10/2004
8EnzymesIBA
11/2021 - 06/2002
8Interleukin-6 (Interleukin 6)IBA
01/2018 - 07/2003
7AntioxidantsIBA
11/2021 - 06/2002
7CollagenIBA
01/2020 - 01/2014
7ElastinIBA
07/2019 - 05/2014
6GasesIBA
12/2020 - 01/2011
6Vitamin DFDA LinkGeneric
10/2017 - 08/2011
6LeptinIBA
06/2016 - 06/2010
6LipopolysaccharidesIBA
10/2014 - 01/2002
54-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
01/2018 - 09/2014
4Carbon DioxideIBA
01/2021 - 11/2016
4Advanced Glycation End ProductsIBA
11/2020 - 08/2012
4Biological ProductsIBA
03/2020 - 08/2002
4Surface-Active Agents (Surfactants)IBA
01/2017 - 12/2006
4Silicon Dioxide (Silica)FDA LinkGeneric
01/2016 - 02/2012
4Glutamic Acid (Glutamate)FDA Link
06/2008 - 09/2005
3Vitamin KFDA Link
12/2021 - 11/2017
3Reactive Oxygen Species (Oxygen Radicals)IBA
11/2021 - 01/2005
3Morphine (MS Contin)FDA LinkGeneric
01/2021 - 11/2017
3Retinaldehyde (Retinal)IBA
11/2020 - 09/2018
3Glucose (Dextrose)FDA LinkGeneric
03/2020 - 07/2011
3AllergensIBA
01/2020 - 01/2016
3Opioid Analgesics (Opioids)IBA
01/2020 - 11/2017
3Receptor for Advanced Glycation End ProductsIBA
01/2018 - 10/2013
3Interleukin-8 (Interleukin 8)IBA
01/2018 - 07/2003
3Protein CIBA
01/2017 - 12/2006
3Carbon MonoxideIBA
01/2017 - 02/2008
3N(6)-carboxymethyllysine (carboxymethyllysine)IBA
02/2014 - 08/2012
3AdiponectinIBA
09/2013 - 07/2011
3Fibrinogen (Factor I)FDA Link
09/2012 - 02/2008
3Pharmaceutical PreparationsIBA
01/2011 - 07/2009
3Phenylalanine (L-Phenylalanine)FDA Link
02/2007 - 08/2005
3Glutamine (L-Glutamine)FDA Link
05/2006 - 10/2004
3Uric Acid (Urate)IBA
10/2005 - 07/2003
2vitamin K1 hydroquinoneIBA
12/2021 - 07/2019
2NADPH Oxidases (NAD(P)H oxidase)IBA
11/2021 - 01/2021
2Glutathione (Reduced Glutathione)IBA
01/2021 - 06/2008
2Oxidants (Oxidizing Agents)IBA
01/2021 - 03/2007
2Anabolic Androgenic SteroidsIBA
09/2019 - 11/2003
2Peptide Hydrolases (Proteases)FDA Link
01/2019 - 12/2004
2Volatile Organic CompoundsIBA
01/2019 - 02/2016
2Protease Inhibitors (Protease Inhibitor)IBA
01/2019 - 11/2010
2SteroidsIBA
11/2017 - 01/2009
2Branched-Chain Amino AcidsIBA
06/2017 - 02/2007
2beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA
10/2016 - 12/2011
2Clostridium perfringens epsilon-toxinIBA
04/2016 - 06/2012

Therapy/Procedure

17Therapeutics
01/2019 - 01/2003
11Palliative Care (Palliative Therapy)
01/2021 - 05/2008
7Activities of Daily Living (ADL)
10/2020 - 03/2012
6Terminal Care (Care, Terminal)
01/2019 - 05/2008
4Artificial Respiration (Mechanical Ventilation)
02/2021 - 05/2011
3Cardiopulmonary Resuscitation (CPR)
02/2021 - 05/2011
3Resistance Training
09/2014 - 05/2008
2Pneumonectomy (Lung Volume Reduction)
01/2022 - 01/2019
2Noninvasive Ventilation
11/2019 - 09/2019
2Respiratory Therapy (Therapy, Respiratory)
11/2018 - 01/2018